Home » Topics » Regulatory

Regulatory
RSS

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Nov. 3, 1997

Clinical data reported for Actiq

Nov. 3, 1997

FDA clears generic cimetidine

Oct. 29, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

Effexor XR cleared by FDA

Oct. 28, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...